BioWave(R) Announces New Clinical Data Demonstrating Impactful Non-Invasive Pain Relief for War-Related Injuries and Home-Based Treatments

In collaboration with Imperial College Healthcare in London and the Regional Clinical Hospital of Ivano-Frankivsk in Ukraine, an ongoing study evaluated BioWave's non-invasive neuromodulation ...
Los Angeles Times

Children’s Hospital Los Angeles Launches First-of-Its-Kind Sleep App

The CHLA-developed app will collect data for future research in machine learning to detect sleep disorders and help advance the standards of pediatric care in pain and sleep medicine Children’s ...
MarketWatch

Artelo Biosciences Stock Rises on Positive Trial Data for Treatment for Persistent Pain

Shares of Artelo Biosciences rose after the company reported positive data for its first in-human trial for a potential non-opioid treatment for persistent pain. The stock more than doubled to $16.30 ...
Morningstar

Unmasking Pain: U.S. Pain Foundation Releases Landmark Data for Pain Awareness Month 2025

WEST HARTFORD, Conn., Sept. 2, 2025 /PRNewswire/ -- Chronic pain is not just a code in a chart or a number on a pain scale—it's a life-altering, deeply distressing experience. More than 1 in 4 ...
Hosted on MSN

Tonix up after peer reviewed data for pain therapy and new data for mpox vaccine

Tonix Pharmaceuticals (NASDAQ:TNXP) added ~10% on Thursday after the company announced peer-reviewed data from a Phase 3 trial for its pain therapy candidate TNX-102 SL, and new findings related to ...
Benzinga.com

Tonix Pharma's Drug Gets FDA Nod For Chronic Pain Condition, First New Therapy In Over 15 Years

On Friday, the U.S. Food and Drug Administration (FDA) approved Tonix Pharmaceuticals Holding Corp.’s (NASDAQ:TNXP) Tonmya (cyclobenzaprine HCl sublingual tablets) for fibromyalgia in adults.